MedTrace Logo

Effects of Resistant Potato Starch on the Gut Microbiota

NCT05242913 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2022-02-16

No results posted yet for this study

Summary

This was a randomized, double-blind, three-arm, parallel group clinical trial, which assessed the shifts that occur in microbial populations after four weeks of supplementation with resistant potato starch (SolnulTM) at two different dosages, in comparison to a placebo in healthy adults.

Conditions

  • Microbiota

Interventions

DIETARY_SUPPLEMENT

Resistant Potato Starch

Unmodified potato starch containing \>60% resistant starch Type 2

DIETARY_SUPPLEMENT

Placebo

Fully digestible corn starch

Sponsors & Collaborators

  • MSP Starch Products Inc.

    lead INDUSTRY

Principal Investigators

  • Anthony Beir, MD · Nutrasource Pharmaceutical and Nutraceutical Services

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-30
Primary Completion
2020-01-06
Completion
2020-01-06

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05242913 on ClinicalTrials.gov